$1000 Invested In Regeneron Pharmaceuticals 20 Years Ago Would Be Worth This Much Today

Why is Intel planning major layoffs in 2025? How will Trump’s tariffs impact US auto industry? What caused Meta to stop political ads in EU? Why did S&P 500 hit multiple record highs recently? How is Tesla advancing its robotaxi service? What’s behind Paramount-Skydance $8B merger approval? How will US release of frozen education funds affect schools?

$1000 Invested In Regeneron Pharmaceuticals 20 Years Ago Would Be Worth This Much Today

benzinga.com/insights/news/25/07/46645844/1000-invested-in-regeneron-pharmaceuticals-20-years-ago-would-be-worth-this-much-today

Regeneron Pharmaceuticals (NASDAQ:REGN) has outperformed the market over the past 20 years by 13.72% on an annualized basis producing an average annual return of 22.23%. Currently, Regeneron Pharmaceuticals has a market capitalization of $60.80 billion.
Buying $1000 In REGN: If ...
Full…

This story appeared on benzinga.com, 2025-07-25 22:00:24.